DMAA
Drugs Made In America Acquisition Corp. Rights
NASDAQ: DMAAR · ·
$0.12
+0.00% today
Updated 2026-10-16
Market cap
$1.83M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$—
Dividend yield
—
52W range
$0 – $0
Volume
0.0M
Drugs Made In America Acquisition Corp. Rights (DMAAR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item |
|---|
| Revenue |
| Revenue growth (YoY) |
| Cost of revenue |
| Gross profit |
| Gross margin |
| R&D |
| SG&A |
| Operating income |
| Operating margin |
| EBITDA |
| EBITDA margin |
| EBIT |
| Interest expense |
| Income tax |
| Effective tax rate |
| Net income |
| Net income growth (YoY) |
| Profit margin |